dibekacin and Graft-vs-Host-Disease

dibekacin has been researched along with Graft-vs-Host-Disease* in 1 studies

Other Studies

1 other study(ies) available for dibekacin and Graft-vs-Host-Disease

Article	Year
First Case of Skin and Soft Tissue Infection Caused by Mycoplasma hominis in a Pediatric Immunocompromised Patient. Annals of laboratory medicine, 2017, Volume: 37, Issue:4 Topics: Adolescent; Anti-Bacterial Agents; Dibekacin; DNA, Bacterial; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Mycoplasma hominis; Mycoplasma Infections; Polymerase Chain Reaction; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tigecycline; Transplantation, Homologous	2017

Article

Year

First Case of Skin and Soft Tissue Infection Caused by Mycoplasma hominis in a Pediatric Immunocompromised Patient.

Annals of laboratory medicine, 2017, Volume: 37, Issue:4

Topics: Adolescent; Anti-Bacterial Agents; Dibekacin; DNA, Bacterial; Female; Graft vs Host Disease; Humans; Immunocompromised Host; Mycoplasma hominis; Mycoplasma Infections; Polymerase Chain Reaction; Soft Tissue Infections; Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization; Tigecycline; Transplantation, Homologous

2017